Clinical Trial Update: Parathyroid Hormone Level and Growth in Pediatric Patients With ESRD on Regular Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating parathyroid hormone level and growth in pediatric patients with end-stage renal disease on regular hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease in Pediatric Patients
• Growth Impairment in Children with Renal Disease

Snippet

Sponsor: Tanta University | Conditions: Drug Effect | Phase 4 | Status: COMPLETED